Cardin, Sophie <br/><br/>
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.  [electronic resource] 

 -  Blood advances  11 2019 
 - 3307-3321 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2473-9537 
<br/><br/><label>Standard No.: </label>10.1182/bloodadvances.2019030981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biomarkers<br/>Biomarkers, Tumor--genetics<br/>Computational Biology--methods<br/>Disease Models, Animal<br/>Disease Susceptibility<br/>Gene Expression<br/>Gene Expression Profiling<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Immunophenotyping<br/>Leukemia, Megakaryoblastic, Acute--etiology<br/>Mice<br/>Neoplastic Stem Cells--metabolism<br/>Nuclear Pore Complex Proteins--genetics<br/>Oncogene Proteins, Fusion--genetics<br/>Retinoblastoma-Binding Protein 2--genetics<br/>Xenograft Model Antitumor Assays